Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Frontiers in Pharmacology
|
January 16, 2014
Regional siderosis: a new challenge for iron chelation therapy
Zvi Ioav Cabantchik, Arnold Munnich, Moussa B Youdim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 11, 2015
Neuroprotective and neurorestorative potential of propargylamine derivatives in ageing: focus on mitochondrial targets
Orit Bar-Am, Tamar Amit, Moussa B Youdim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 29, 2019
Selegiline: a molecule with innovative potential
Tamás Tábi, László Vécsei, Moussa B Youdim, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 17, 2009
TVP1022 protects neonatal rat ventricular myocytes against doxorubicin-induced functional derangements
Alexandra Berdichevski, Gideon Meiry, Felix Milman, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease
Luisa S Pimentel, Simon Allard, Sonia Do Carmo, et al.
Neuropharmacology
|
January 26, 2016
Binge ethanol exposure increases the Krüppel-like factor 11-monoamine oxidase (MAO) pathway in rats: Examining the use of MAO inhibitors to prevent ethanol-induced brain injury
Jeremy W Duncan, Xiao Zhang, Niping Wang, et al.
Journal of Medicinal Chemistry
|
November 15, 2002
Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease
Jeffrey Sterling, Yaacov Herzig, Tamar Goren, et al.
Science Translational Medicine
|
October 8, 2010
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease
Bin Zheng, Zhixiang Liao, Joseph J Locascio, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Frontiers in Pharmacology
|
January 16, 2014
Regional siderosis: a new challenge for iron chelation therapy
Zvi Ioav Cabantchik, Arnold Munnich, Moussa B Youdim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 11, 2015
Neuroprotective and neurorestorative potential of propargylamine derivatives in ageing: focus on mitochondrial targets
Orit Bar-Am, Tamar Amit, Moussa B Youdim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 29, 2019
Selegiline: a molecule with innovative potential
Tamás Tábi, László Vécsei, Moussa B Youdim, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 17, 2009
TVP1022 protects neonatal rat ventricular myocytes against doxorubicin-induced functional derangements
Alexandra Berdichevski, Gideon Meiry, Felix Milman, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease
Luisa S Pimentel, Simon Allard, Sonia Do Carmo, et al.
Neuropharmacology
|
January 26, 2016
Binge ethanol exposure increases the Krüppel-like factor 11-monoamine oxidase (MAO) pathway in rats: Examining the use of MAO inhibitors to prevent ethanol-induced brain injury
Jeremy W Duncan, Xiao Zhang, Niping Wang, et al.
Journal of Medicinal Chemistry
|
November 15, 2002
Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease
Jeffrey Sterling, Yaacov Herzig, Tamar Goren, et al.
Science Translational Medicine
|
October 8, 2010
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease
Bin Zheng, Zhixiang Liao, Joseph J Locascio, et al.
Page
of 1